Model of Tumor Dormancy/Recurrence after Short-Term Chemotherapy

Open Access

Peer-reviewed

Research Article

Shenduo Li,

Affiliation Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America
⨯
Margaret Kennedy,

Affiliation Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America
⨯
Sturgis Payne,

Affiliation Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America
⨯
Kelly Kennedy,

Affiliation Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America
⨯
Victoria L. Seewaldt,

Affiliation Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America
⨯
Salvatore V. Pizzo,

Affiliation Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America
⨯
Robin E. Bachelder

* E-mail: robin. bachelder@duke.edu

Affiliation Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America
⨯

Reader Comments (0)

Cancer chemotherapy
Is the Subject Area "Cancer chemotherapy" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Combination chemotherapy
Is the Subject Area "Combination chemotherapy" applicable to this article?

Thanks for your feedback.
Prostate gland
Is the Subject Area "Prostate gland" applicable to this article?

Thanks for your feedback.
Breast tumors
Is the Subject Area "Breast tumors" applicable to this article?

Thanks for your feedback.
Thymidines
Is the Subject Area "Thymidines" applicable to this article?

Thanks for your feedback.